These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4208289)

  • 41. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Susceptibility of nonfermentative gram-negative bacilli to tobramycin.
    Uwaydah M; Taqi-Eddin AR
    J Infect Dis; 1976 Aug; 134 Suppl():S28-32. PubMed ID: 823278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides.
    Watanakunakorm C; Glotzbecker C
    Antimicrob Agents Chemother; 1974 Dec; 6(6):802-6. PubMed ID: 4451352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
    Chandrasekar PH; Schell RF; LeFrock JL; Rolston KV; Francisco M
    Chemotherapy; 1984; 30(3):165-9. PubMed ID: 6428812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibacterial activity of ticarcillin, tobramycin and gentamicin alone and in combination against Pseudomonas aeruginosa in vitro.
    Ullmann U
    Chemotherapy; 1977; 23(5):314-23. PubMed ID: 409590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
    Matzkowitz AJ; Baltch AL; Smith RP; Sutphen NT; Hammer MC; Conroy JV
    Antimicrob Agents Chemother; 1982 Apr; 21(4):685-7. PubMed ID: 6805426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
    Pfaller M; Bale M; Preston T; Howard W; Koontz F
    Diagn Microbiol Infect Dis; 1986 May; 5(1):17-23. PubMed ID: 3086026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative evaluation of five aminoglycosides for treatment.
    Rosin H; Naumann P; Reintjens E; Köhler M
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tobramycin: comparative in vitro susceptibility studies.
    Jedlickova Z; Ryc M
    Chemotherapy; 1974; 20(5):303-14. PubMed ID: 4213506
    [No Abstract]   [Full Text] [Related]  

  • 52. Antipseudomonal drugs: comparative study of gentamicin, sisomicin and tobramycin in vitro and in human volunteers.
    Klastersky J; Henri A; Hensgens C; Vandenborre L; Daneau D
    Eur J Cancer (1965); 1973 Sep; 9(9):641-8. PubMed ID: 4214702
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.
    Ducan IB; Penner JL
    Can Med Assoc J; 1975 Jul; 113(1):29-31. PubMed ID: 807310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.
    Meyer RD; Lewis RP; Halter J; White M
    Lancet; 1976 Mar; 1(7959):580-3. PubMed ID: 55850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin.
    Crowe CC; Sanders E
    Antimicrob Agents Chemother; 1973 Jan; 3(1):24-8. PubMed ID: 4790572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aminoglycoside resistance among blood culture isolates.
    Huovinen P; Grönroos P; Herva E; Katila ML; Klossner ML; Renkonen OV; Toivanen P
    J Clin Microbiol; 1984 Jul; 20(1):65-9. PubMed ID: 6378968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of sisomicin, an aminoglycoside antibiotic, against clinical isolates.
    Stewart D; Bodey GP
    J Antibiot (Tokyo); 1975 Feb; 28(2):149-55. PubMed ID: 234415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.
    Briedis DJ; Robson HG
    Antimicrob Agents Chemother; 1976 Oct; 10(4):592-7. PubMed ID: 825032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of the "in vitro" activity of three aminoglycosides (gentamicin, tobramycin, and sisomicin) against "pseudomonas aeruginosa" strains (author's transl)].
    Berti P; Maranini B; Mazzoni P; Mori S
    Ann Sclavo; 1978; 20(5):696-706. PubMed ID: 111631
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro studies of tobramycin.
    Bodey GP; Stewart D
    Antimicrob Agents Chemother; 1972 Sep; 2(3):109-13. PubMed ID: 4790551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.